Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Boston Scientific SIMPLAAFY trial

Tag: Boston Scientific SIMPLAAFY trial

Boston Scientific cardiovascular devices outlook after SIMPLAAFY WATCHMAN FLX Pro data
  • Medical Devices

Boston Scientific’s SIMPLAAFY Trial Reports Positive Results for WATCHMAN FLX Pro Post-Implant Treatment

Megan Wood5 hours ago010 mins

Why Boston Scientific cardiovascular devices stay in focus: SIMPLAAFY data on WATCHMAN FLX Pro, what is investigational, and what the company has not said.

Read More

Categories

  • Healthcare IT (25)
  • Industry Insights (335)
  • Lifestyle and Wellness (24)
  • Medical Devices (43)
  • Pharmaceuticals (88)
  • Uncategorized (1)

Recent Posts

  • Shilpa CDMO Invests $50 Million to Expand Peptide Manufacturing Capacity in India
  • Alembic Pharmaceuticals Q2 FY27 Profit Jumps 81% on Strong US Business
  • Apollo Hospitals Q2 FY27 Results: Net Profit Rises 32% as Revenue Grows 23%
  • NHS Launches World-First Multi-Cancer Blood Test Trial Across 200 GP Practices
  • Edwards Lifesciences’ PASCAL System Shows Positive One-Year Results in CLASP II TR Trial
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.